Search research articles
Contact Us
Filters
Showing results (561-570 of 595) with videos related to
Page
of 60
Sort By:
Journal of Geophysical Research. Atmospheres : JGR
|
April 17, 2025
Anthropogenic Extremely Low Volatility Organics (ELVOCs) Govern the Growth of Molecular Clusters Over the Southern Great Plains During the Springtime
Manish Shrivastava, Jie Zhang, Rahul A Zaveri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia
Farhad Ravandi, Jorge E Cortes, Daniel Jones, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 22, 2023
Delineating clinical and developmental outcomes in <i>STXBP1</i>-related disorders
Julie Xian, Kim Marie Thalwitzer, Jillian McKee, et al.
Journal of Clinical Microbiology
|
January 24, 2024
Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates
E Misas, E Seagle, E N Jenkins, et al.
Brain : a Journal of Neurology
|
November 28, 2023
Delineating clinical and developmental outcomes in STXBP1-related disorders
Julie Xian, Kim Marie Thalwitzer, Jillian McKee, et al.
Scientific Reports
|
January 26, 2019
Whole Transcriptome Analysis of Renal Intercalated Cells Predicts Lipopolysaccharide Mediated Inhibition of Retinoid X Receptor alpha Function
Vijay Saxena, James Fitch, John Ketz, et al.
Scientific Reports
|
March 19, 2020
Publisher Correction: Whole Transcriptome Analysis of Renal Intercalated Cells Predicts Lipopolysaccharide Mediated Inhibition of Retinoid X Receptor alpha Function
Vijay Saxena, James Fitch, John Ketz, et al.
Blood Advances
|
January 4, 2018
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Prajwal Boddu, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
Journal of Clinical Microbiology
|
May 22, 2024
Erratum for Misas et al., "Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates"
E Misas, E Seagle, E N Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2012
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome
Guillermo Garcia-Manero, Francesco Paolo Tambaro, Nebiyou B Bekele, et al.
Page
of 60
Search research articles
Search
Showing results (561-570 of 595) with videos related to
Sort By:
Page
of 60
Journal of Geophysical Research. Atmospheres : JGR
|
April 17, 2025
Anthropogenic Extremely Low Volatility Organics (ELVOCs) Govern the Growth of Molecular Clusters Over the Southern Great Plains During the Springtime
Manish Shrivastava, Jie Zhang, Rahul A Zaveri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 2010
Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia
Farhad Ravandi, Jorge E Cortes, Daniel Jones, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 22, 2023
Delineating clinical and developmental outcomes in <i>STXBP1</i>-related disorders
Julie Xian, Kim Marie Thalwitzer, Jillian McKee, et al.
Journal of Clinical Microbiology
|
January 24, 2024
Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates
E Misas, E Seagle, E N Jenkins, et al.
Brain : a Journal of Neurology
|
November 28, 2023
Delineating clinical and developmental outcomes in STXBP1-related disorders
Julie Xian, Kim Marie Thalwitzer, Jillian McKee, et al.
Scientific Reports
|
January 26, 2019
Whole Transcriptome Analysis of Renal Intercalated Cells Predicts Lipopolysaccharide Mediated Inhibition of Retinoid X Receptor alpha Function
Vijay Saxena, James Fitch, John Ketz, et al.
Scientific Reports
|
March 19, 2020
Publisher Correction: Whole Transcriptome Analysis of Renal Intercalated Cells Predicts Lipopolysaccharide Mediated Inhibition of Retinoid X Receptor alpha Function
Vijay Saxena, James Fitch, John Ketz, et al.
Blood Advances
|
January 4, 2018
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Prajwal Boddu, Hagop M Kantarjian, Guillermo Garcia-Manero, et al.
Journal of Clinical Microbiology
|
May 22, 2024
Erratum for Misas et al., "Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial <i>Candida glabrata</i> isolates"
E Misas, E Seagle, E N Jenkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2012
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome
Guillermo Garcia-Manero, Francesco Paolo Tambaro, Nebiyou B Bekele, et al.
Page
of 60